Correlation Between Blue Owl and Grace Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Blue Owl and Grace Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blue Owl and Grace Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blue Owl Capital and Grace Therapeutics,, you can compare the effects of market volatilities on Blue Owl and Grace Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blue Owl with a short position of Grace Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blue Owl and Grace Therapeutics,.
Diversification Opportunities for Blue Owl and Grace Therapeutics,
0.52 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Blue and Grace is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Blue Owl Capital and Grace Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Grace Therapeutics, and Blue Owl is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blue Owl Capital are associated (or correlated) with Grace Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Grace Therapeutics, has no effect on the direction of Blue Owl i.e., Blue Owl and Grace Therapeutics, go up and down completely randomly.
Pair Corralation between Blue Owl and Grace Therapeutics,
Considering the 90-day investment horizon Blue Owl Capital is expected to generate 0.46 times more return on investment than Grace Therapeutics,. However, Blue Owl Capital is 2.18 times less risky than Grace Therapeutics,. It trades about 0.08 of its potential returns per unit of risk. Grace Therapeutics, is currently generating about 0.02 per unit of risk. If you would invest 1,139 in Blue Owl Capital on October 4, 2024 and sell it today you would earn a total of 1,200 from holding Blue Owl Capital or generate 105.36% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Blue Owl Capital vs. Grace Therapeutics,
Performance |
Timeline |
Blue Owl Capital |
Grace Therapeutics, |
Blue Owl and Grace Therapeutics, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Blue Owl and Grace Therapeutics,
The main advantage of trading using opposite Blue Owl and Grace Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blue Owl position performs unexpectedly, Grace Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Grace Therapeutics, will offset losses from the drop in Grace Therapeutics,'s long position.Blue Owl vs. Visa Class A | Blue Owl vs. Diamond Hill Investment | Blue Owl vs. Distoken Acquisition | Blue Owl vs. AllianceBernstein Holding LP |
Grace Therapeutics, vs. Vaccinex | Grace Therapeutics, vs. Vigil Neuroscience | Grace Therapeutics, vs. Viracta Therapeutics | Grace Therapeutics, vs. Dogwood Therapeutics, |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |